Is it safe to administer boosting agents via the peripheral route: a systematic review and meta-analysis
Hypertensive drugs are administered via central vein in both adults and children due to concerns about extravascular leakage and local tissue ischemia. It has been recommended to give the drug to patients with septic shock. However, in time-sensitive conditions, such as septic shock, the use of intravenous The time required to insert a cardiac intravenous catheter leads to a delay in the initiation of boosting medications. Therefore, we looked at the extent to which safety can be ensured by administering a boosting drug through a peripheral vein. Here are some sentences
If you would like to read further, please join our mailing list or read the NOTE.
Comments